Marco Tampellini Selected Research

Marco Tampellini Research Topics

Disease

27	Colorectal Neoplasms (Colorectal Cancer) 11/2022 - 01/2004
17	Neoplasms (Cancer) 01/2021 - 01/2005
9	Neoplasm Metastasis (Metastasis) 01/2018 - 01/2007
5	Prostatic Neoplasms (Prostate Cancer) 12/2012 - 01/2005
4	Breast Neoplasms (Breast Cancer) 01/2011 - 06/2004
2	Neutropenia 04/2023 - 07/2013
2	Adenocarcinoma 01/2018 - 11/2010
2	Disease Progression 12/2017 - 01/2014
2	Fatigue 07/2013 - 12/2012
1	Lung Neoplasms (Lung Cancer) 04/2023
1	Infections 04/2023
1	Anemia 11/2022
1	Exanthema (Rash) 11/2022
1	Inflammation (Inflammations) 01/2020
1	Pain (Aches) 12/2018
1	Death (Near-Death Experience) 12/2018
1	Hypoxia (Hypoxemia) 05/2018
1	Adrenal Cortex Neoplasms (Adrenocortical Cancer) 11/2017
1	Adrenocortical Carcinoma 11/2017
1	Hepatocellular Carcinoma (Hepatoma) 10/2016
1	Hypersensitivity (Allergy) 10/2016
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2014
1	Purpura 12/2014
1	Thrombosis (Thrombus) 12/2014
1	Hypoglycemia (Reactive Hypoglycemia) 01/2014
1	Insulinoma 01/2014
1	Hyperglycemia 01/2014
1	Colonic Neoplasms (Colon Cancer) 10/2013
1	Weight Loss (Weight Reduction) 07/2013
1	Brain Diseases (Brain Disorder) 05/2013
1	Body Weight (Weight, Body) 12/2012
1	Secondary Hyperparathyroidism 01/2012
1	Rectal Neoplasms (Rectal Cancer) 10/2007
1	Bone Resorption 01/2007

Drug/Important Bio-Agent (IBA)

13	Oxaliplatin (Eloxatin)FDA LinkGeneric 02/2018 - 01/2004
10	Fluorouracil (Carac)FDA LinkGeneric 09/2019 - 08/2006
10	Leucovorin (Folinic Acid)FDA Link 09/2019 - 08/2006
6	Panitumumab (Vectibix)FDA Link 11/2022 - 10/2013
5	Biomarkers (Surrogate Marker)IBA 01/2020 - 08/2006
2	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 11/2015 - 01/2014
2	Epirubicin (Ellence)FDA LinkGeneric 11/2005 - 06/2004
2	Hormones (Hormone)IBA 11/2005 - 01/2005
1	Tyrosine Kinase InhibitorsIBA 04/2023
1	Immune Checkpoint InhibitorsIBA 04/2023
1	LigandsIBA 04/2023
1	Doxycycline (Periostat)FDA LinkGeneric 07/2021
1	Epidermal Growth Factor (EGF)IBA 09/2019
1	Opioid Analgesics (Opioids)IBA 12/2018
1	EnzymesIBA 05/2018
1	CytokinesIBA 05/2018
1	Thymidine PhosphorylaseIBA 05/2018
1	pyrimidineIBA 05/2018
1	Mitotane (Lysodren)FDA Link 11/2017
1	2,2- (2- chlorophenyl- 4'- chlorophenyl)acetic acidIBA 11/2017
1	2,2- (2- chlorophenyl- 4'- chlorophenyl)- 1,1- dichloroetheneIBA 11/2017
1	Pemetrexed (MTA)FDA Link 12/2014
1	thiamine triphosphorate (TTP)IBA 12/2014
1	Everolimus FDA Link 01/2014
1	Insulin (Novolin)FDA Link 01/2014
1	XELOXIBA 10/2013
1	Capecitabine (Xeloda)FDA Link 10/2013
1	enzalutamideIBA 12/2012
1	Diphosphonates (Bisphosphonates)IBA 01/2012
1	Zoledronic Acid (Zometa)FDA Link 01/2012
1	Parathyroid Hormone (Parathormone)IBA 01/2012
1	Chromogranin AIBA 11/2010
1	Antineoplastic Agents (Antineoplastics)IBA 05/2010
1	Gemcitabine FDA Link 09/2008
1	Irinotecan (Camptosar)FDA LinkGeneric 09/2008
1	Alkaline PhosphataseIBA 04/2008
1	Transforming Growth Factor alpha (TGF-alpha)IBA 03/2007
1	ErbB Receptors (EGF Receptor)IBA 03/2007
1	Ribosomal Protein S6 Kinases (S6 Kinase)IBA 03/2007
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 03/2007
1	AnthracyclinesIBA 08/2006
1	Prostate-Specific Antigen (Semenogelase)IBA 01/2005
1	Etoposide (VP 16)FDA LinkGeneric 01/2005
1	Estramustine FDA Link 01/2005

Therapy/Procedure

21	Drug Therapy (Chemotherapy) 04/2023 - 06/2004
13	Therapeutics 04/2023 - 08/2006
2	Folfox protocol 01/2018 - 01/2004
2	Chronotherapy 04/2008 - 08/2006
1	Immunotherapy 04/2023
1	Duration of Therapy 01/2021
1	Palliative Care (Palliative Therapy) 12/2018
1	Molecular Targeted Therapy 10/2016
1	Radiofrequency Ablation 05/2013
1	Thoracotomy 02/2011
1	Metastasectomy 02/2011
1	Neoadjuvant Therapy 11/2010
1	Radiotherapy 11/2010
1	Prostatectomy (Retropubic Prostatectomy) 01/2005